PlainRecalls
FDA Drug Moderate Class II Ongoing

Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg, 3 Units, 3x28 tablets blister cards per carton, Rx only, Manufactured for AvKARE, Pulaski, TN 38478. Carton NDC: 42291-565-84; Blister NDC: 42291-565-28

Reported: October 15, 2025 Initiated: September 2, 2025 #D-0007-2026

Product Description

Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg, 3 Units, 3x28 tablets blister cards per carton, Rx only, Manufactured for AvKARE, Pulaski, TN 38478. Carton NDC: 42291-565-84; Blister NDC: 42291-565-28

Reason for Recall

Failed Content Uniformity Specifications

Details

Recalling Firm
AvKARE
Units Affected
2192 cartons
Distribution
U.S. Nationwide
Location
Pulaski, TN

Frequently Asked Questions

What product was recalled?
Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg, 3 Units, 3x28 tablets blister cards per carton, Rx only, Manufactured for AvKARE, Pulaski, TN 38478. Carton NDC: 42291-565-84; Blister NDC: 42291-565-28. Recalled by AvKARE. Units affected: 2192 cartons.
Why was this product recalled?
Failed Content Uniformity Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on October 15, 2025. Severity: Moderate. Recall number: D-0007-2026.